TCI Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,143
| Closed | -$94.9K | – | 1002 |
|
|
2023
Q1 | $94.9K | Sell |
1,143
-46
| -4% | -$3.81K | 0.01% | 288 |
|
|
2022
Q4 | $102K | Buy |
1,189
+59
| +5% | +$4.67K | 0.01% | 260 |
|
|
2022
Q3 | $70K | Sell |
1,130
-7
| -0.6% | -$441 | 0.01% | 303 |
|
|
2022
Q2 | $70K | Buy |
1,137
+437
| +62% | +$27.1K | 0.01% | 303 |
|
|
2022
Q1 | $41K | Sell |
700
-272
| -28% | -$17.4K | 0.01% | 461 |
|
|
2021
Q4 | $71K | Buy |
972
+258
| +36% | +$17.8K | 0.01% | 323 |
|
|
2021
Q3 | $50K | Buy |
714
+29
| +4% | +$2.04K | 0.01% | 419 |
|
|
2021
Q2 | $47K | Buy |
685
+50
| +8% | +$3.34K | 0.01% | 405 |
|
|
2021
Q1 | $41K | Sell |
635
-192
| -23% | -$12.4K | 0.02% | 390 |
|
|
2020
Q4 | $48K | Buy |
827
+16
| +2% | +$965 | 0.02% | 337 |
|
|
2020
Q3 | $51K | Sell |
811
-14
| -2% | -$971 | 0.02% | 309 |
|
|
2020
Q2 | $63K | Buy |
825
+191
| +30% | +$14.6K | 0.03% | 272 |
|
|
2020
Q1 | $47K | Sell |
634
-117
| -16% | -$8.08K | 0.02% | 318 |
|
|
2019
Q4 | $49K | Buy |
751
+5
| +0.7% | +$326 | 0.02% | 392 |
|
|
2019
Q3 | $47K | Sell |
746
-60
| -7% | -$3.92K | 0.02% | 341 |
|
|
2019
Q2 | $54K | Sell |
806
-58
| -7% | -$3.82K | 0.02% | 296 |
|
|
2019
Q1 | $56K | Buy |
864
+97
| +13% | +$6.45K | 0.02% | 316 |
|
|
2018
Q4 | $48K | Sell |
767
-10
| -1% | -$699 | 0.02% | 319 |
|
|
2018
Q3 | $60K | Sell |
777
-238
| -23% | -$18K | 0.03% | 306 |
|
|
2018
Q2 | $72K | Sell |
1,015
-7
| -0.7% | -$494 | 0.03% | 263 |
|
|
2018
Q1 | $77K | Sell |
1,022
-19
| -2% | -$1.51K | 0.04% | 261 |
|
|
2017
Q4 | $75K | Sell |
1,041
-3
| -0.3% | -$228 | 0.03% | 277 |
|
|
2017
Q3 | $85K | Sell |
1,044
-217
| -17% | -$16.6K | 0.04% | 231 |
|
|
2017
Q2 | $89K | Buy |
1,261
+115
| +10% | +$7.65K | 0.05% | 214 |
|
|
2017
Q1 | $78K | Sell |
1,146
-345
| -23% | -$24.3K | 0.04% | 240 |
|
|
2016
Q4 | $107K | Hold |
1,491
| – | – | 0.06% | 214 |
|
|
2016
Q3 | $118K | Sell |
1,491
-235
| -14% | -$19.1K | 0.06% | 191 |
|
|
2016
Q2 | $144K | Sell |
1,726
-340
| -16% | -$30.2K | 0.08% | 159 |
|
|
2016
Q1 | $190K | Buy |
2,066
+210
| +11% | +$18.9K | 0.11% | 134 |
|
|
2015
Q4 | $188K | Buy |
1,856
+515
| +38% | +$53.6K | 0.1% | 138 |
|
|
2015
Q3 | $132K | Buy |
1,341
+215
| +19% | +$23.9K | 0.08% | 168 |
|
|
2015
Q2 | $132K | Buy |
1,126
+433
| +62% | +$47.3K | 0.08% | 169 |
|
|
2015
Q1 | $68K | Sell |
693
-13
| -2% | -$1.32K | 0.04% | 212 |
|
|
2014
Q4 | $67K | Sell |
706
-206
| -23% | -$21.3K | 0.04% | 217 |
|
|
2014
Q3 | $97K | Buy |
912
+100
| +12% | +$9.79K | 0.06% | 172 |
|
|
2014
Q2 | $67K | Hold |
812
| – | – | 0.04% | 220 |
|
|
2014
Q1 | $58K | Hold |
812
| – | – | 0.04% | 220 |
|
|
2013
Q4 | $61K | Sell |
812
-338
| -29% | -$23.5K | 0.04% | 221 |
|
|
2013
Q3 | $72K | Hold |
1,150
| – | – | 0.05% | 179 |
|
|
2013
Q2 | $59K | Buy |
+1,150
| New | +$59.9K | 0.04% | 206 |
|
Other funds holding GILD
TCI Wealth Advisors's GILD Position: Q2 2023 in Review
TCI Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 1,143 shares — an estimated $94.9K sold.
TCI Wealth Advisors first reported a position in GILD in Q2 2013 and held it in 40 quarters. The position peaked at $190K in Q1 2016. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.
- TCI Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 1,143 Gilead Sciences shares in Q2 2023, an estimated $94.9K.
- TCI Wealth Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 40 quarters.
- TCI Wealth Advisors's Gilead Sciences position peaked at $190K in Q1 2016.
- 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.